Amgen names Thomas Dittrich as new CFO, succeeding Peter Griffith in September 2026

Amgen announced that Peter Griffith will retire as CFO, effective September 1, 2026, with Thomas Dittrich returning to the company to take over the role. Dittrich, who has over 30 years of experience in finance and the biopharmaceutical industry, will begin as executive vice president on July 1 and oversee all financial operations. Griffith will stay on until January 2027 to ensure a smooth transition. This leadership change aims to support Amgen's long-term growth and financial strategy.